1. Home
  2. SMWB vs PHVS Comparison

SMWB vs PHVS Comparison

Compare SMWB & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMWB
  • PHVS
  • Stock Information
  • Founded
  • SMWB 2007
  • PHVS 2015
  • Country
  • SMWB Israel
  • PHVS Netherlands
  • Employees
  • SMWB N/A
  • PHVS N/A
  • Industry
  • SMWB Computer Software: Programming Data Processing
  • PHVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMWB Technology
  • PHVS Health Care
  • Exchange
  • SMWB Nasdaq
  • PHVS Nasdaq
  • Market Cap
  • SMWB 1.0B
  • PHVS 1.0B
  • IPO Year
  • SMWB 2021
  • PHVS 2021
  • Fundamental
  • Price
  • SMWB $14.51
  • PHVS $19.57
  • Analyst Decision
  • SMWB Strong Buy
  • PHVS Strong Buy
  • Analyst Count
  • SMWB 8
  • PHVS 5
  • Target Price
  • SMWB $13.50
  • PHVS $40.60
  • AVG Volume (30 Days)
  • SMWB 625.6K
  • PHVS 110.9K
  • Earning Date
  • SMWB 02-11-2025
  • PHVS 11-13-2024
  • Dividend Yield
  • SMWB N/A
  • PHVS N/A
  • EPS Growth
  • SMWB N/A
  • PHVS N/A
  • EPS
  • SMWB N/A
  • PHVS N/A
  • Revenue
  • SMWB $241,081,000.00
  • PHVS N/A
  • Revenue This Year
  • SMWB $16.83
  • PHVS N/A
  • Revenue Next Year
  • SMWB $14.41
  • PHVS N/A
  • P/E Ratio
  • SMWB N/A
  • PHVS N/A
  • Revenue Growth
  • SMWB 13.39
  • PHVS N/A
  • 52 Week Low
  • SMWB $5.03
  • PHVS $15.37
  • 52 Week High
  • SMWB $14.72
  • PHVS $33.00
  • Technical
  • Relative Strength Index (RSI)
  • SMWB 73.28
  • PHVS 47.85
  • Support Level
  • SMWB $12.56
  • PHVS $18.01
  • Resistance Level
  • SMWB $13.53
  • PHVS $20.17
  • Average True Range (ATR)
  • SMWB 0.72
  • PHVS 1.33
  • MACD
  • SMWB 0.05
  • PHVS 0.01
  • Stochastic Oscillator
  • SMWB 92.12
  • PHVS 56.45

About SMWB Similarweb Ltd.

Similarweb Ltd provides a platform for digital intelligence, delivering a trusted, comprehensive, and detailed view of the digital world that empowers customers to accelerate their growth and become more competitive in the markets. Its proprietary technology analyzes billions of digital interactions and transactions every day from millions of websites and apps and turns these digital signals into actionable insights. The company generates revenues mainly from SaaS subscriptions, which comprise subscription fees from customers utilizing cloud-based digital intelligence solutions and other subscription-based solutions. Geographically, the majority of its revenue is derived from the United States and rest from Israel, United Kingdom, Europe, Asia Pacific and other regions.

About PHVS Pharvaris N.V.

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .

Share on Social Networks: